Prophase Labs Inc PRPH

$0.01 0.00 (-9.00%)

Valuation

Market cap
209,000
Revenue TTM
$4,350,000
Net income TTM
$-14,740,000
PE ratio
0.00
Forward PE
—
Profit margin
-338.85%
Debt to equity
-1.80

Trading

Volume
626,800
Avg volume
322,816
Day's range
$0.01 – $0.01
Shares out
20,912,000
Stochastic %K
9%
Beta
0.13
Analysts
Strong Buy
Price target
$11.00

Price

Company profile

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer...

Show more

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their DNA data from previous DNA tests obtained from other service providers; and LB-1 and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory related syndromes, diseases or symptoms, including dementia and Alzheimer's disease. In addition, the company provides Nebula focuses on genomics testing technologies a comprehensive method for analyzing entire genomes, including the genes and chromosomes in deoxyribonucleic acid (DNA). It offers its genome sequencing products to consumers online with plans to sell in food, drug, and mass retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Uniondale, New York.

Industry
Diagnostics & Research
Sector
Healthcare
Phone
516 989 0763
Website
https://www.prophaselabs.com
Address
626 RXR Plaz, 6th Floor, Uniondale, United States

Latest news

No headlines yet.